Covered recipient · General Payments record
GINA A MATHEW
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$2,865.18
- Reported across 211 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $406.68 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $296.40 | 20 |
| Corcept Therapeutics | $46.24 | 3 |
| Phathom Pharmaceuticals, Inc. | $18.93 | 1 |
| Otsuka America Pharmaceutical, Inc. | $16.00 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $15.48 | 1 |
| Esperion Therapeutics, Inc. | $13.63 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $26.14 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104982647 | CMS |
| ABBVIE INC. | $8.45 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104982649 | CMS |
| ABBVIE INC. | $7.02 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104982651 | CMS |
| ABBVIE INC. | $26.07 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104982653 | CMS |
| ABBVIE INC. | $9.46 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104982655 | CMS |
| ABBVIE INC. | $31.66 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104982657 | CMS |
| ABBVIE INC. | $28.12 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104982659 | CMS |
| ABBVIE INC. | $5.91 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104982661 | CMS |
| ABBVIE INC. | $6.49 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104982663 | CMS |
| ABBVIE INC. | $10.83 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104982665 | CMS |
| ABBVIE INC. | $5.48 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104982667 | CMS |
| ABBVIE INC. | $25.53 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104982669 | CMS |
| ABBVIE INC. | $14.17 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104982671 | CMS |
| ABBVIE INC. | $3.83 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104982673 | CMS |
| ABBVIE INC. | $18.33 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104982675 | CMS |
| ABBVIE INC. | $3.78 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104982677 | CMS |
| ABBVIE INC. | $28.75 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104982679 | CMS |
| ABBVIE INC. | $26.09 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104982681 | CMS |
| ABBVIE INC. | $4.55 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104982683 | CMS |
| ABBVIE INC. | $5.74 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104982685 | CMS |
| Corcept Therapeutics | $14.58 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117777404 | CMS |
| Corcept Therapeutics | $14.40 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117777434 | CMS |
| Corcept Therapeutics | $17.26 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117777460 | CMS |
| Esperion Therapeutics, Inc. | $13.63 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129446010 | CMS |
| Novartis Pharmaceuticals Corporation | $15.48 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087100560 | CMS |
| Otsuka America Pharmaceutical, Inc. | $16.00 | 12/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118937500 | CMS |
| Phathom Pharmaceuticals, Inc. | $18.93 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151094087 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.